Generic placeholder image

Protein & Peptide Letters

Editor-in-Chief

ISSN (Print): 0929-8665
ISSN (Online): 1875-5305

Reduced NGF Secretion by HT-29 Human Colon Cancer Cells Treated with a GRPR Antagonist

Author(s): Caroline Brunetto de Farias, Laura Stertz, Rodrigo Cruz Lima, Flavio Kapczinski, Gilberto Schwartsmann and Rafael Roesler

Volume 16, Issue 6, 2009

Page: [650 - 652] Pages: 3

DOI: 10.2174/092986609788490177

Price: $65

Abstract

The gastrin-releasing peptide receptor (GRPR) is a therapeutic target in colon cancer. Here we show that the GRPR antagonist RC-3095 (10 , 10 , or 1 μM) decreases nerve growth factor (NGF) secretion measured by enzymelinked immunosorbent assay (ELISA) in HT-29 human colon carcinoma cells. The results suggest that decreased secretion of neurotrophins might be a novel mechanism by which GRPR antagonists exert their antiproliferative effects in cancer cells.

Keywords: Gastrin-releasing peptide receptor, RC-3095, nerve growth factor, colon cancer


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy